These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 15305333)
1. Lysophosphatidic acid promotes survival of androgen-insensitive prostate cancer PC3 cells via activation of NF-kappaB. Raj GV; Sekula JA; Guo R; Madden JF; Daaka Y Prostate; 2004 Oct; 61(2):105-13. PubMed ID: 15305333 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Li Y; Sarkar FH Clin Cancer Res; 2002 Jul; 8(7):2369-77. PubMed ID: 12114442 [TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Shukla S; Maclennan GT; Marengo SR; Resnick MI; Gupta S Prostate; 2005 Aug; 64(3):224-39. PubMed ID: 15712212 [TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation. Hwang YS; Lee J; Zhang X; Lindholm PF Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305 [TBL] [Abstract][Full Text] [Related]
5. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836 [TBL] [Abstract][Full Text] [Related]
6. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells. Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070 [TBL] [Abstract][Full Text] [Related]
8. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726 [TBL] [Abstract][Full Text] [Related]
9. Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. Lee SO; Lou W; Nadiminty N; Lin X; Gao AC Prostate; 2005 Jul; 64(2):160-7. PubMed ID: 15678501 [TBL] [Abstract][Full Text] [Related]
10. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis. Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665 [TBL] [Abstract][Full Text] [Related]
13. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. St-Germain ME; Gagnon V; Parent S; Asselin E Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316 [TBL] [Abstract][Full Text] [Related]
14. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343 [TBL] [Abstract][Full Text] [Related]
15. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells. Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705 [TBL] [Abstract][Full Text] [Related]
17. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
18. Acacetin (5,7-dihydroxy-4'-methoxyflavone) exhibits in vitro and in vivo anticancer activity through the suppression of NF-κB/Akt signaling in prostate cancer cells. Kim HR; Park CG; Jung JY Int J Mol Med; 2014 Feb; 33(2):317-24. PubMed ID: 24285354 [TBL] [Abstract][Full Text] [Related]
19. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Vandermoere F; El Yazidi-Belkoura I; Adriaenssens E; Lemoine J; Hondermarck H Oncogene; 2005 Aug; 24(35):5482-91. PubMed ID: 15856005 [TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]